KIF18A inhibitor therapy(Accent Therapeutics)

N/A

Report date: 2024/03/04 17:43:42

Base Information

Drug NameKIF18A inhibitor therapy(Accent Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF18A inhibitors
TargetsKinesin-like protein KIF18A
Therapy Area/IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAccent Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAccent Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A